GlaxoSmithkline’s success will be evaluated next week as the giant formed by the biggest-ever pharmaceuticals merger reports its latest annual results, the first since its official union on December 27.
Sales from its constituent companies continued to grow during the third quarter. GlaxoWelcome’s revenue was #6.7bn and Smithkline Beecham’s #2.2bn. The union was announced in January 2000, and originally due to complete that summer. But despite winning EU approval in May and shareholder approval in August, the merger was delayed twice because of US anti-trust investigations. The #130bn merger was approved by UK courts and the US federal trade commission in December 2000.
Just one half of UK practices have implemented a pricing structure around auto enrolment implementation and advice - with many suffering increased costs
Deloitte's north-west Europe foray; BDO, Smith & Williamson investment paths; Shelley Stock Hutter; and Wilkins Kennedy discussed by editor Kevin Reed on our Friday Afternoon Live broadcast
Accountants should alter their perspective on auto-enrolment to maximise business opportunities, according to Eric Clapton.
Kevin Reed discusses whether new accountancy group Cogital can rival the Big Four...and its likely direction of travel